76
Participants
Start Date
August 28, 2019
Primary Completion Date
December 1, 2024
Study Completion Date
September 30, 2030
Docosahexaenoic acid (DHA)
Participants will take 11 capsules of DHA oil for 12-18 weeks (84-126 days), beginning on day 1 of initial cycle of chemotherapy, and continuing for 4-6 cycles of chemotherapy prior to definitive breast surgery. Study will end when subject undergoes breast surgery.
Placebo oral capsule
Participants will take 11 capsules of placebo (corn/soy oil blend) for 12-18 weeks (84-126 days), beginning on day 1 of initial cycle of chemotherapy, and continuing for 4-6 cycles of chemotherapy prior to definitive breast surgery. Study will end when subject undergoes breast surgery.
Cross Cancer Institute, Edmonton
Canadian Institutes of Health Research (CIHR)
OTHER_GOV
University of Alberta
OTHER
AHS Cancer Control Alberta
OTHER